41
zovirax
Skip itA concentrated shelf (top 5 take 95% of clicks) — this niche doesn't clear our bar today.
Returns
Incredible0.2%return rate — above 5% kills the launch gate
Conversion
Great9.7%search→purchase rate — share of searches ending in a sale
Review moat
Good868avg incumbent reviews — the moat a new listing must climb
Avg price
Good€12.95avg listing price — sweet spot $15–$100
Quality gap
Good4.4★avg incumbent rating — lower means beatable quality
Price range
Good€5.18–€25.19cheapest to priciest tracked listing — scored on the share inside $15–$100
Market size
Okay€132K€132K/yr · 106K searches
Growth
Bad-22.4%90-day search growth — must beat 0% to launch
Brand share
Bad95%top-5 brand share — brand-locked demand
Competition
Bad95%top-5 click share — a locked-up shelf
Signals Low Review Barrier